1. Home
  2. PMEC vs NERV Comparison

PMEC vs NERV Comparison

Compare PMEC & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Primech Holdings Ltd.

PMEC

Primech Holdings Ltd.

SELL

Current Price

$0.55

Market Cap

23.4M

Sector

N/A

ML Signal

SELL

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$3.47

Market Cap

166.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMEC
NERV
Founded
1984
2007
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.4M
166.4M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
PMEC
NERV
Price
$0.55
$3.47
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $10.33
AVG Volume (30 Days)
105.2K
★ 116.0K
Earning Date
07-24-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $41,175,600.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$2.24
52 Week High
$2.44
$12.46

Technical Indicators

Market Signals
Indicator
PMEC
NERV
Relative Strength Index (RSI) 52.31 38.74
Support Level $0.50 N/A
Resistance Level $0.81 $4.73
Average True Range (ATR) 0.09 0.25
MACD -0.00 -0.01
Stochastic Oscillator 47.35 37.32

Price Performance

Historical Comparison
PMEC
NERV

About PMEC Primech Holdings Ltd.

Primech Holdings Ltd is a Singapore-based facilities services and AI robotics group with operations in Singapore and Hong Kong. Through its subsidiaries, the company provides integrated facilities management, cleaning and stewarding services to the public and private sectors, serving airports, educational institutions, healthcare facilities, commercial buildings and hospitality venues. It also develops HYTRON, an autonomous restroom-cleaning robot that uses AI perception and robotic manipulation. In addition, the company operates HomeHelpy, a digital platform for booking home services for consumers.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: